| Name | Title | Contact Details |
|---|
Bioject Medical Technologies Inc. is a leader in the development of needle-free injection therapies with over 25 years of experience improving the administration of liquid medications; pharmaceuticals, vaccines, and biologics. Bioject's technology works by forcing liquid medication at high speed through a tiny orifice held against the skin. This creates an ultra-fine stream of fluid that penetrates the skin, delivering medication in a fraction of a second. Bioject's systems are designed to deliver injected medications comfortably, accurately, and quickly - without the use of a needle. Bioject was founded in 1985 to develop needle-free injection systems to improve the comfort and safety of routine injections. From its early work focused on improving the characteristics of these delivery systems, the Company has created a broad technology platform for delivering a wide range of medications and vaccines to the subcutaneous, intramuscular and intradermal depths. Bioject has developed a portfolio of injection systems based on its core technology, the foundation for which is more than 80 issued and pending patents and an extensive body of technical know-how. These include durable devices designed for heavy use in a professional healthcare environment, and small, lightweight injectors designed for home use. With partners, Bioject is also developing inexpensive, pre-filled, disposable injection systems. Further validating its technology, Bioject and its partners have the largest volume of published studies using needle-free injection technology systems. Bioject's strategy is to form strategic partnerships with pharmaceutical, biotechnology, and animal health companies. The result is mutually beneficial agreements with these partners to develop customized injection systems to enhance the delivery of their injected medication or vaccine. Bioject has alliances with leading pharmaceutical, biotechnology, and animal health companies. Bioject's products are also used in public health, Physicians offices, and in cutting edge biomedical research at leading institutions around the globe.
Mikron Digital Imaging is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Katahdin Industries provides high-tolerance coating applications and specialized metal-finishing technology and services to the medical device and industrial markets through platform-focused subsidiaries including DCHN, Precision Coating, Medi-Solve Coatings and Sanford Process. Headquartered in Dedham, Mass., with operations in Woonsocket, R.I., Katahdin has earned an industry reputation as an innovative, high-quality supplier. Katahdin's technical and product development expertise, strong facilities and problem-solving culture have resulted in a track record of successful service performance for its customers. Each subsidiary is an expert provider of the services it offers. But mastery of the technology is only part of our competitive differentiation. Developing unique capabilities to handle specific applications, whether coating medical wire or finishing orthopedic equipment, allows us to provide these and other related services at a superior quality level and lower cost than other service providers. Katahdin's coating operations are conducted through Precision Coating Company, Inc., one of the largest plastics coating applicators in the world, specializing in PTFE and Teflon® coating applications in the medical device market. A separate co-located company, Precision Fabric, is a worldwide distributor and converter of PTFE-coated fabrics, tapes and belts. Specialized metal finishing services are conducted through DCHN, LLC, an industry leader in technical aluminum and titanium anodizing, electro-polish and passivation, and other related services. Sanford Process Corporation provides hard-coat anodizing solutions, as well as licenses the company's intellectual property, to a range of well-known OEMs and their prime subcontractors worldwide, with an increasing presence in Korea and China. Katahdin seeks to acquire expert service providers and formulators with a strong history of innovation, current facilities, dedicated customer service, and high-quality management. The company's acquisition strategy is flexible, offering the potential for owners to retain a stake in the business. By leveraging Katahdin's capabilities, acquired companies are able to increase growth and profitability by focusing on their customers and technology needs while expanding sales and marketing reach.
Ambulatory care at Hotel Dieu Hospital (HDH) is specialized care that may include a scheduled visit to one or more hospital clinics, diagnostic or procedural areas. In some cases, a single health care professional, for example a surgeon or internal medicine physician, may see patients in a traditional clinic setting. Increasingly, patients and families will receive care in a team-based inter-disciplinary and/or inter-professional program, such as our pre-surgical screening, diabetes, breast assessment, bariatric, chronic pain or cardiac rehabilitation programs. Ambulatory care at HDH includes care for patients with urgent and less critical emergency problems at our Urgent Care Centre. Hotel Dieu Hospital has a very active ambulatory surgery program where most patients return home the same day. We also have a short-stay facility in the form of a satellite post-anesthetic care unit that supports patients who need extended time for pain control and rehabilitation therapy. This facility is key to our innovative fast-track total hip and knee arthroplasty program. Hotel Dieu Hospital is a faith-based, academic hospital where research and learning take place every day and where we are committed to partnership with patients and families. We actively engage in implementing innovative models of care that support patient care, as well as regional and academic health care needs. Affiliated with Queen`s University, we serve as a major teaching location for learners from across the Faculty of Health Sciences, including medical, nursing and allied health learners. And research at Hotel Dieu Hospital contributes to the growing field of knowledge about health care and ambulatory care in Canada and beyond. Ambulatory care at Hotel Dieu Hospital is part of an integrated, cost-effective system of health care in Southeastern Ontario.
At 4Catalyzer we are transforming 21st century medicine by solving today’s most challenging problems – across life science tools, medical devices and therapeutics. We aspire to create significant societal impact and are motivated by the idea that our products will change the lives of people we love. We seek the talent of truly gifted, self-starting and driven individuals to help advance this mission. We provide a stimulating environment, surrounded by brilliant, highly committed individuals who are given both the autonomy and project ownership to solve difficult problems and be the first to publish. Each 4Catalyzer company endeavors to develop technologies that enable unprecedented looks at nature thereby affording the opportunity to do prize-winning science and publish in top-tier journals like Science and Nature. Our advisors have pioneered their fields. Our technology base includes truly novel Devices, Deep Learning and the Cloud. We understand that success requires surrounding yourself with the right people, being at the right place at the right time, and having the resources to get the job done.